Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2018

06.12.2017 | Head and Neck

Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis

verfasst von: Haimei Qin, Rong Wang, Guijiang Wei, Huaifei Wang, Guogang Pan, Rentong Hu, Yesheng Wei, Renguang Tang, Junli Wang

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Nasopharyngeal carcinoma (NPC), a malignant tumor at the top and side of the nasopharyngeal cavity, highly occurs in the southern region of China. Cancer cell metastasis is one of the leading causes of death in NPC patients. Osteopontin (OPN), is a phosphorylated extracellular matrix protein with a variety of functions, was found to be overexpressed in many cancers. However, the expression and role of OPN in patients with NPC in Guangxi, China are unclear. Here, we observed that NPC patients had upregulated OPN at mRNA protein and levels. Immunochemistry (IHC) analysis of OPN expression in 68 NPC clinical specimens indicated that high expression of OPN had positive correlation with NPC lymph node metastasis (P = 0.012), distant metastasis (P = 0.001) and TNM staging (P = 0.018). Moreover, compared with relatively low OPN, NPC patients with higher expression of OPN showed a poorer overall survival rate (P = 0.001, log rank test). Multivariate analysis showed that OPN expression in NPC was an independent prognostic marker. The proliferation, apoptosis and migration ability of CEN-2Z cancer cells in NPC were determined by MTT, flow cytometry and wound-healing assays, respectively. Upregulation of OPN in CEN-2Z cancer cells promoted cancer cell proliferation and migration, and suppressed apoptosis. In sum, our result suggests OPN could be used as a valuable oncoprotein and show that overexpression of OPN in NPC may serve as a potential prognostic marker.
Literatur
1.
Zurück zum Zitat Chapman CH, Parvathaneni U, Yom SS (2017) Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma. Future Oncol 13:581–584CrossRefPubMed Chapman CH, Parvathaneni U, Yom SS (2017) Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma. Future Oncol 13:581–584CrossRefPubMed
2.
Zurück zum Zitat Wee JT, Ha TC, Loong SL, Qian CN. (2010) Is nasopharyngeal cancer really a “Cantonese cancer”?. Chin J Cancer 29: 517–26CrossRefPubMed Wee JT, Ha TC, Loong SL, Qian CN. (2010) Is nasopharyngeal cancer really a “Cantonese cancer”?. Chin J Cancer 29: 517–26CrossRefPubMed
3.
Zurück zum Zitat Lin JH, Jiang CQ, Ho SY, Zhang WS, Mai ZM, Xu L, Lo CM, Lam TH (2015) Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China. BMC Cancer 15:906CrossRefPubMedPubMedCentral Lin JH, Jiang CQ, Ho SY, Zhang WS, Mai ZM, Xu L, Lo CM, Lam TH (2015) Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China. BMC Cancer 15:906CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wei Z, Zeng X, Xu J, Duan X, Yang J, Xie Y (2014) Prognostic value of the pretreatment serum level of cytokeratin fraction 21–1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases. Head Neck 36:71–76CrossRefPubMed Wei Z, Zeng X, Xu J, Duan X, Yang J, Xie Y (2014) Prognostic value of the pretreatment serum level of cytokeratin fraction 21–1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases. Head Neck 36:71–76CrossRefPubMed
5.
Zurück zum Zitat Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, Feng QS, Low HQ, Zhang H, He F, Tai ES, Kang T, Liu ET et al (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42:599–603CrossRefPubMed Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, Feng QS, Low HQ, Zhang H, He F, Tai ES, Kang T, Liu ET et al (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42:599–603CrossRefPubMed
7.
8.
Zurück zum Zitat Zhang R, Pan X, Huang Z, Weber GF, Zhang G (2011) Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One 6:e23831CrossRefPubMedPubMedCentral Zhang R, Pan X, Huang Z, Weber GF, Zhang G (2011) Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One 6:e23831CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Zhao XQ, Dong JH, Zhang WZ, Liu Z (2011) Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin. Diagn Pathol 6:98CrossRefPubMedPubMedCentral Zhao XQ, Dong JH, Zhang WZ, Liu Z (2011) Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin. Diagn Pathol 6:98CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Yu TT, Han ZG, Shan L, Tao J, Zhang T, Yuan SF, Shen HL (2014) Expression of osteopontin in non-small cell lung cancer and correlative relation with microvascular density. Asian Pac J Cancer Prev 15:29–32CrossRefPubMed Yu TT, Han ZG, Shan L, Tao J, Zhang T, Yuan SF, Shen HL (2014) Expression of osteopontin in non-small cell lung cancer and correlative relation with microvascular density. Asian Pac J Cancer Prev 15:29–32CrossRefPubMed
11.
Zurück zum Zitat Qiu Y, Hu Y, Zhang ZY, Ye L, Xu FH, Schneider ME, Ma XL, Du YX, Zuo XB, Zhou FS, Chen G, Xie XS, Zhang Y et al (2014) Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients. J Cancer Res Clin Oncol 140:2143–2156CrossRefPubMed Qiu Y, Hu Y, Zhang ZY, Ye L, Xu FH, Schneider ME, Ma XL, Du YX, Zuo XB, Zhou FS, Chen G, Xie XS, Zhang Y et al (2014) Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients. J Cancer Res Clin Oncol 140:2143–2156CrossRefPubMed
12.
Zurück zum Zitat Zhang H, Guo M, Chen JH, Wang Z, Du XF, Liu PX, Li WH (2014) Osteopontin knockdown inhibits alphav,beta3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway. Cell Physiol Biochem 33:991–1002CrossRefPubMed Zhang H, Guo M, Chen JH, Wang Z, Du XF, Liu PX, Li WH (2014) Osteopontin knockdown inhibits alphav,beta3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway. Cell Physiol Biochem 33:991–1002CrossRefPubMed
13.
Zurück zum Zitat Wang HH, Wang XW, Tang CE (2011) Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease. J Cancer Res Ther 7:138–142CrossRefPubMed Wang HH, Wang XW, Tang CE (2011) Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease. J Cancer Res Ther 7:138–142CrossRefPubMed
14.
Zurück zum Zitat Phillips RJ, Helbig KJ, Van der Hoek KH, Seth D, Beard MR (2012) Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 18:3389–3399CrossRefPubMedPubMedCentral Phillips RJ, Helbig KJ, Van der Hoek KH, Seth D, Beard MR (2012) Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 18:3389–3399CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N, Lan F, Liu Y, Yan S, Dong X, Cai L (2013) Prognostic values of osteopontin-c, E-cadherin and beta-catenin in breast cancer. Cancer Epidemiol 37:985–992CrossRefPubMed Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N, Lan F, Liu Y, Yan S, Dong X, Cai L (2013) Prognostic values of osteopontin-c, E-cadherin and beta-catenin in breast cancer. Cancer Epidemiol 37:985–992CrossRefPubMed
16.
Zurück zum Zitat Luo W, Fang W, Li S, Yao K (2012) Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer 131:1863–1873CrossRefPubMed Luo W, Fang W, Li S, Yao K (2012) Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer 131:1863–1873CrossRefPubMed
17.
Zurück zum Zitat Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14:6996–7003CrossRefPubMed Li J, Guan HY, Gong LY, Song LB, Zhang N, Wu J, Yuan J, Zheng YJ, Huang ZS, Li M (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 14:6996–7003CrossRefPubMed
18.
Zurück zum Zitat Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L (2011) Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549. Med Oncol 28:565–571CrossRefPubMed Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L (2011) Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549. Med Oncol 28:565–571CrossRefPubMed
19.
Zurück zum Zitat Senger DR, Wirth DF, Hynes RO. (1979) Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell. 16: 885–893CrossRefPubMed Senger DR, Wirth DF, Hynes RO. (1979) Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell. 16: 885–893CrossRefPubMed
20.
Zurück zum Zitat Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2010) Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 14:2037–2044CrossRefPubMedPubMedCentral Anborgh PH, Mutrie JC, Tuck AB, Chambers AF (2010) Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 14:2037–2044CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Higashi A, Dohi Y, Uraoka N, Sentani K, Uga S, Kinoshita H, Sada Y, Kitagawa T, Hidaka T, Kurisu S, Yamamoto H, Yasui W, Kihara Y (2015) The potential role of inflammation associated with interaction between osteopontin and CD44 in a case of pulmonary tumor thrombotic microangiopathy caused by breast cancer. Intern Med 54:2877–2880CrossRefPubMed Higashi A, Dohi Y, Uraoka N, Sentani K, Uga S, Kinoshita H, Sada Y, Kitagawa T, Hidaka T, Kurisu S, Yamamoto H, Yasui W, Kihara Y (2015) The potential role of inflammation associated with interaction between osteopontin and CD44 in a case of pulmonary tumor thrombotic microangiopathy caused by breast cancer. Intern Med 54:2877–2880CrossRefPubMed
23.
Zurück zum Zitat Wai PY, Kuo PC (2008) Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27:103–118CrossRefPubMed Wai PY, Kuo PC (2008) Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27:103–118CrossRefPubMed
24.
Zurück zum Zitat Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ (2016) The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res 18:14CrossRefPubMedPubMedCentral Xu K, Tian X, Oh SY, Movassaghi M, Naber SP, Kuperwasser C, Buchsbaum RJ (2016) The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res 18:14CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Anborgh PH, Caria LB, Chambers AF, Tuck AB, Stitt LW, Brackstone M (2015) Role of plasma osteopontin as a biomarker in locally advanced breast cancer. Am J Transl Res 7:723–732PubMedPubMedCentral Anborgh PH, Caria LB, Chambers AF, Tuck AB, Stitt LW, Brackstone M (2015) Role of plasma osteopontin as a biomarker in locally advanced breast cancer. Am J Transl Res 7:723–732PubMedPubMedCentral
26.
Zurück zum Zitat Gu X, Gao XS, Ma M, Qin S, Qi X, Li X, Sun S, Yu H, Wang W, Zhou D (2016) Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Oncotarget 7:69666–69673PubMedPubMedCentral Gu X, Gao XS, Ma M, Qin S, Qi X, Li X, Sun S, Yu H, Wang W, Zhou D (2016) Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Oncotarget 7:69666–69673PubMedPubMedCentral
27.
Zurück zum Zitat Hui EP, Sung FL, Yu BK, Wong CS, Ma BB, Lin X, Chan A, Wong WL, Chan AT (2008) Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer. Clin Cancer Res 14:7080–7087CrossRefPubMed Hui EP, Sung FL, Yu BK, Wong CS, Ma BB, Lin X, Chan A, Wong WL, Chan AT (2008) Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer. Clin Cancer Res 14:7080–7087CrossRefPubMed
28.
Zurück zum Zitat Hou X, Wu X, Huang P, Zhan J, Zhou T, Ma Y, Qin T, Luo R, Feng Y, Xu Y, Chen L, Zhang L (2015) Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma. Int J Cancer 137:1672–1678CrossRefPubMed Hou X, Wu X, Huang P, Zhan J, Zhou T, Ma Y, Qin T, Luo R, Feng Y, Xu Y, Chen L, Zhang L (2015) Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma. Int J Cancer 137:1672–1678CrossRefPubMed
29.
Zurück zum Zitat Chen J, Zhu C, He Z, Geng M, Li G, Tao X, Zhang F (2015) Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma. Int J Clin Exp Med 8:7116–7124PubMedPubMedCentral Chen J, Zhu C, He Z, Geng M, Li G, Tao X, Zhang F (2015) Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma. Int J Clin Exp Med 8:7116–7124PubMedPubMedCentral
30.
Zurück zum Zitat Stemberger C, Matusan-Ilijas K, Avirovic M, Bulat-Kardum L, Ivancic A, Jonjic N, Lucin K (2014) Osteopontin is associated with decreased apoptosis and alphav integrin expression in lung adenocarcinoma. Acta Histochem 116:222–229CrossRefPubMed Stemberger C, Matusan-Ilijas K, Avirovic M, Bulat-Kardum L, Ivancic A, Jonjic N, Lucin K (2014) Osteopontin is associated with decreased apoptosis and alphav integrin expression in lung adenocarcinoma. Acta Histochem 116:222–229CrossRefPubMed
31.
Zurück zum Zitat Ma R, Luo X, Feng S, Li J, Fan Y, Wen W, Li H (2014) Osteopontin promotes EZH2 expression and tumor progression in nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 76:273–281CrossRefPubMed Ma R, Luo X, Feng S, Li J, Fan Y, Wen W, Li H (2014) Osteopontin promotes EZH2 expression and tumor progression in nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec 76:273–281CrossRefPubMed
32.
Zurück zum Zitat Jiang S, Chen X, Li C, Zhang X, Zhang T, Yue Y, Yang G (2012) Suramin inhibits the growth of nasopharyngeal carcinoma cells via the downregulation of osteopontin. Mol Med Rep 6:1351–1354CrossRefPubMed Jiang S, Chen X, Li C, Zhang X, Zhang T, Yue Y, Yang G (2012) Suramin inhibits the growth of nasopharyngeal carcinoma cells via the downregulation of osteopontin. Mol Med Rep 6:1351–1354CrossRefPubMed
33.
Zurück zum Zitat Yang G, Zhang Y, Wu J, Xiong J, Deng H, Wang J, Yang C, Zhu Z (2011) Osteopontin regulates growth and migration of human nasopharyngeal cancer cells. Mol Med Rep 4:1169–1173PubMed Yang G, Zhang Y, Wu J, Xiong J, Deng H, Wang J, Yang C, Zhu Z (2011) Osteopontin regulates growth and migration of human nasopharyngeal cancer cells. Mol Med Rep 4:1169–1173PubMed
Metadaten
Titel
Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis
verfasst von
Haimei Qin
Rong Wang
Guijiang Wei
Huaifei Wang
Guogang Pan
Rentong Hu
Yesheng Wei
Renguang Tang
Junli Wang
Publikationsdatum
06.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-017-4827-x

Weitere Artikel der Ausgabe 2/2018

European Archives of Oto-Rhino-Laryngology 2/2018 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.